These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2640764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activity.
    Alttoa A, Kõiv K, Eller M, Uustare A, Rinken A, Harro J.
    Neuroscience; 2005; 132(4):979-90. PubMed ID: 15857703
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T, Lemmer B.
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice.
    Hanania T, Zahniser NR.
    Alcohol Clin Exp Res; 2002 Apr; 26(4):431-40. PubMed ID: 11981117
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of dopamine uptake by a new psychostimulant mesocarb (Sydnocarb).
    Erdö SL, Kiss B, Rosdy B.
    Pol J Pharmacol Pharm; 1981 Apr; 33(2):141-7. PubMed ID: 7312716
    [Abstract] [Full Text] [Related]

  • 13. Differential behavioural effects after subtotal depletions of dopamine or noradrenaline in the ventral striatum.
    Schwarting RK, Carey RJ.
    Funct Neurol; 1988 Apr; 3(1):29-36. PubMed ID: 3134274
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proceedings: Biochemical evidence for the involvement of noradrenaline in motor activity produced by L-DOPA in rodents.
    Dolphin A, Jenner P, Marsden CD.
    Br J Pharmacol; 1975 Oct; 55(2):292P. PubMed ID: 1201420
    [No Abstract] [Full Text] [Related]

  • 17. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
    Kõks S, Volke V, Veraksits A, Rünkorg K, Sillat T, Abramov U, Bourin M, Huotari M, Männistö PT, Matsui T, Vasar E.
    Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
    Kozyrska C, Zebrowska-Lupina I.
    Pol J Pharmacol Pharm; 1983 Nov; 35(2):115-26. PubMed ID: 6684769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.